Emergent BioSolutions Inc. financial data

Symbol
EBS on NYSE
Location
Gaithersburg, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 30 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 523% % 316%
Quick Ratio 246% % 302%
Debt-to-equity 164% % -18%
Return On Assets 5.3% %
Operating Margin -10% % 85%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52,519,964 shares -3.1%
Common Stock, Shares, Outstanding 52,700,000 shares -2.6%
Entity Public Float $360,700,000 USD -5.3%
Common Stock, Value, Issued $100,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 53,200,000 shares 0.19%
Weighted Average Number of Shares Outstanding, Diluted 56,500,000 shares 1.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $1,043,600,000 USD -0.54%
Revenue from Contract with Customer, Excluding Assessed Tax $231,100,000 USD -21%
Research and Development Expense $50,200,000 USD -45%
Operating Income (Loss) $118,500,000 USD 19%
Nonoperating Income (Expense) $12,600,000 USD 53%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $105,900,000 USD -60%
Income Tax Expense (Benefit) $30,000,000 USD -23%
Net Income (Loss) Attributable to Parent $75,900,000 USD -55%
Earnings Per Share, Basic 1 USD/shares -56%
Earnings Per Share, Diluted 1 USD/shares -56%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $245,500,000 USD 64%
Accounts Receivable, after Allowance for Credit Loss, Current $149,500,000 USD 23%
Inventory, Net $356,300,000 USD 10%
Assets, Current $786,900,000 USD 19%
Property, Plant and Equipment, Net $209,800,000 USD -25%
Operating Lease, Right-of-Use Asset $7,200,000 USD -42%
Intangible Assets, Net (Excluding Goodwill) $452,700,000 USD -13%
Goodwill $0 USD
Other Assets, Noncurrent $11,600,000 USD -43%
Assets $1,461,000,000 USD -1.1%
Accounts Payable, Current $57,400,000 USD -30%
Employee-related Liabilities, Current $36,600,000 USD -42%
Accrued Liabilities, Current $13,900,000 USD -14%
Contract with Customer, Liability, Current $6,100,000 USD -16%
Liabilities, Current $136,500,000 USD -41%
Deferred Income Tax Liabilities, Net $36,300,000 USD -13%
Operating Lease, Liability, Noncurrent $6,100,000 USD -43%
Other Liabilities, Noncurrent $42,600,000 USD 19%
Liabilities $878,500,000 USD -9.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax $7,500,000 USD -2.7%
Retained Earnings (Accumulated Deficit) $105,200,000 USD 42%
Stockholders' Equity Attributable to Parent $582,500,000 USD 15%
Liabilities and Equity $1,461,000,000 USD -1.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $11,200,000 USD 82%
Net Cash Provided by (Used in) Financing Activities $400,000 USD -101%
Net Cash Provided by (Used in) Investing Activities $59,500,000 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 60,600,000 shares 1.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $47,200,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $249,200,000 USD 59%
Interest Paid, Excluding Capitalized Interest, Operating Activities $16,700,000 USD -22%
Deferred Tax Assets, Valuation Allowance $339,000,000 USD 31%
Deferred Tax Assets, Gross $346,200,000 USD 28%
Operating Lease, Liability $7,900,000 USD -41%
Depreciation $33,200,000 USD -30%
Payments to Acquire Property, Plant, and Equipment $3,600,000 USD -67%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $75,700,000 USD -54%
Lessee, Operating Lease, Liability, to be Paid $15,300,000 USD -25%
Property, Plant and Equipment, Gross $500,500,000 USD -26%
Operating Lease, Liability, Current $1,800,000 USD -33%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,800,000 USD -24%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,600,000 USD -16%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 55%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,900,000 USD -6.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,200,000 USD -24%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15,000,000 shares 0%
Unrecognized Tax Benefits $1,700,000 USD -74%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,800,000 USD -22%
Additional Paid in Capital $938,600,000 USD 1.5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $65,100,000 USD 0.15%
Depreciation, Depletion and Amortization $25,400,000 USD -9%
Deferred Tax Assets, Net of Valuation Allowance $7,200,000 USD -38%
Share-based Payment Arrangement, Expense $15,200,000 USD -14%
Interest Expense $94,300,000 USD 101%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%